How are Helium Shortages Impacting Healthcare Supply Chains?

The shortage of helium triggered by the recent Strait of Hormuz closure is exposing vulnerabilities within hospital operations and clinical service delivery that extend far beyond a disrupted gas market.

It is revealing how quickly healthcare facilities can shift from routine service provision to critical resource rationing when energy corridors and trade routes destabilise, forcing clinical leaders to make difficult decisions about diagnostic capacity and patient care pathways.

Iranian strikes on Qatar's Ras Laffan Industrial City, the world's single largest helium source, removed about 30% to 38% of global supply overnight. While the Strait is now open following the US-Iran ceasefire, transportation remains fragile and conflict still threatens the region.

The most immediate impact on hospital systems

The most immediate impact on hospital systems is the constraint on magnetic resonance imaging (MRI) services. These scanners depend on liquid helium to cool superconducting magnets, a requirement that cannot be easily engineered away at scale across global hospital systems.

For radiology departments already managing waiting lists and diagnostic backlogs, reduced MRI availability could mean delayed cancer diagnoses, postponed surgical planning and longer patient pathways through secondary care.

But helium shortages are not the origin of the clinical challenge. They are an early indicator of how far upstream disruption is now reaching into healthcare infrastructure and frontline service delivery.

"We're already hearing of shortages starting to come through in the UK: complex biologics, active pharmaceutical ingredients (APIs), even oncology drugs," Richard Sullivan, Professor of Cancer and Global Health at King's College London, tells the British Medical Journal.

"We're seeing disruption in supply chains for cancer drugs and consumables for robotic surgery, which uses up an awful lot of equipment every time you operate on somebody."

Energy analysts estimate it could take up to five years to restore full capacity at Ras Laffan LNG facility. That alone tightens a market already vulnerable to concentration risk, creating sustained pressure on hospital procurement teams and clinical directors managing service continuity.

Clinical dependency on energy infrastructure

Yet the deeper issue for healthcare providers is not a single facility. It is the instability of the energy corridor that supports clinical supply chains and operational resilience.

The conflict in the Middle East has sparked disruption now feeding through into multiple layers of hospital operations. That could matter significantly because modern healthcare systems are not insulated from petrochemical supply chains. They are built on them.

"We know from past crises that reduced air freight space means supply priority moves to higher value drugs and that strains generics where margins are thin," says Nadya Wells, a medical supply chain researcher at the Geneva Graduate Institute's Global Health Centre, according to the British Medical Journal.

"Then there are the API risks from sea freight costs increasing and routes taking longer."

Pharmaceutical manufacturing depends on oil and gas derivatives for solvents, reagents, catalysts and excipients. Medical plastics, sterile packaging and cleaning systems are similarly dependent.

Even small shifts in feedstock pricing or availability can ripple into hospital procurement costs and clinical service availability.

Logistics is tightening at the same time. Higher fuel prices and disrupted flight routes are reducing air freight capacity, which is critical for temperature sensitive medicines and biologics used in oncology, immunology and critical care.

Sea freight delays are extending lead times for active pharmaceutical ingredients, creating lagged shortages that could affect routine prescribing and treatment protocols.

Degrading capacity across services

Helium illustrates the same logic in physical form for diagnostic departments.

"Deliveries of helium expected from Qatar, if any, that would have arrived in the UK soon, will not be arriving," Phil Kornbluth, president of Kornbluth Helium Consulting, says in the British Medical Journal.

"The UK does not produce helium, nor does it have a storage facility beyond inventory at end users. Nothing that would last months."

MRI systems sit at the far end of the chain. When helium tightens, imaging capacity does not fail immediately. It degrades over time as supply runs down, maintenance becomes harder and replenishment becomes uncertain.

That lag is what makes this crisis significant for clinical leaders. Hospital systems are already absorbing shocks that have not yet fully reached patient care delivery.